AD
Didierlaurent, Arnaud
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Functional and epigenetic changes in monocytes from adults immunized with an AS01-adjuvanted vaccine | Science translational medicine |  | 2024 | 146 | 0 | ||
| Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infection | Pediatric allergy and immunology |  | 2024 | 130 | 394 | ||
| Circulation chez des patients drépanocytaires : en finir avec les bouchons | Revue médicale suisse | | 2024 | 145 | 12 | ||
| One-year longitudinal study of antibody profiles in children : MIS-C versus children with uncomplicated COVID-19 | The Pediatric infectious disease journal | | 2024 | 77 | 133 | ||
| Innate immune cell activation by adjuvant AS01 in human lymph node explants is age-independent | The Journal of clinical investigation | | 2024 | 153 | 259 | ||
| Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America | Frontiers in immunology | | 2024 | 212 | 130 | ||
| A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity | Human vaccines & immunotherapeutics | | 2024 | 17 | 44 | ||
| Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV) : a multicenter, international, non-randomized clinical trial study protocol | BMC infectious diseases | | 2024 | 129 | 391 | ||
| Features of chronic urticaria after COVID-19 mRNA vaccine over time | Communications medicine | | 2024 | 9 | 418 | ||
| Co-administration of COVID-19 and influenza vaccines | Clinical microbiology and infection | | 2023 | 80 | 317 | ||
| Systems analysis of human responses to an aluminium hydroxide-adsorbed TLR7 agonist (AS37) adjuvanted vaccine reveals a dose-dependent and specific activation of the interferon-mediated antiviral response | Vaccine | | 2023 | 388 | 333 | ||
| Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design | npj vaccines | | 2023 | 80 | 28 | ||
| State-of-the-science of human papillomavirus vaccination in women with human immunodeficiency virus : summary of a scientific workshop | Preventive medicine reports | | 2023 | 72 | 26 | ||
| Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | | 2023 | 204 | 54 | ||
| C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonates | Frontiers in immunology | | 2023 | 137 | 125 | ||
| Utility of urinary cytokine levels as predictors of the immunogenicity and reactogenicity of AS01-adjuvanted hepatitis B vaccine in healthy adults | Vaccine | | 2022 | 319 | 170 | ||
| Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | | 2022 | 250 | 175 | ||
| Seul au monde : le naufrage de l’immunité antivirale | Revue médicale suisse | | 2022 | 102 | 151 | ||
| Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine | The Journal of infectious diseases | | 2022 | 259 | 278 | ||
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | | 2022 | 235 | 117 | ||
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | | 2022 | 291 | 209 | ||
| Commentary on "Common vaccines and the risk of dementia: a population-based cohort study": Science can be messy but eventually leads to truths | The Journal of infectious diseases | | 2022 | 245 | 3 | ||
| Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | | 2022 | 201 | 186 | ||
| CCR2- and Flt3-Dependent Inflammatory Conventional Type 2 Dendritic Cells Are Necessary for the Induction of Adaptive Immunity by the Human Vaccine Adjuvant System AS01 | Frontiers in immunology | | 2021 | 184 | 131 | ||
| Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | | 2021 | 441 | 315 | ||
| Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants | npj vaccines | | 2021 | 218 | 91 | ||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | | 2021 | 527 | 348 | ||
| Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | | 2021 | 320 | 209 | ||
| Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19 | Journal of the Pediatric Infectious Diseases Society | | 2021 | 334 | 192 | ||
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | | 2021 | 411 | 246 | ||
| Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data | Vaccine | | 2021 | 343 | 250 | ||
| Pediatric COVID-19: Immunopathogenesis, Transmission and Prevention | Vaccines | | 2021 | 237 | 459 | ||
| Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature | Science translational medicine | | 2020 | 264 | 0 | ||
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | | 2020 | 524 | 225 | ||
| Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines | Vaccine | | 2020 | 595 | 4 | ||
| Toll‐like receptor 4 signaling in hematopoietic‐lineage cells contributes to the enhanced activity of the human vaccine adjuvant AS01 | European Journal of Immunology | | 2019 | 298 | 213 | ||
| Inflammatory parameters associated with systemic reactogenicity following vaccination with adjuvanted hepatitis B vaccines in humans | Vaccine | | 2019 | 375 | 283 | ||
| Application of modeling approaches to explore vaccine adjuvant mode-of-action | Frontiers in Immunology | | 2019 | 244 | 183 | ||
| Clarification regarding the statement of the association between the recombinant zoster vaccine (RZV) and gout flares | Annals of the Rheumatic Diseases | | 2019 | 274 | 189 | ||
| Peripheral lymph nodes contain migratory and resident innate lymphoid cell populations | Science Immunology | | 2019 | 339 | 2 | ||
| The how's and what's of vaccine reactogenicity | NPJ Vaccines | | 2019 | 313 | 255 | ||
| Correlates of adjuvanticity: a review on adjuvants in licensed vaccines | Seminars in Immunology | | 2018 | 329 | 814 | ||
| Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention | Expert Review of Vaccines | | 2018 | 368 | 1 | ||
| Activation of the endoplasmic reticulum stress sensor IRE1α by the vaccine adjuvant AS03 contributes to its immunostimulatory properties | NPJ Vaccines | 2018 | 226 | 0 | |||
| The adjuvant system AS01 up-regulates neutrophil CD14 expression and neutrophil-associated antigen transport in the local lymphatic network | Clinical and Experimental Immunology | | 2018 | 392 | 0 | ||
| Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity | NPJ Vaccines | | 2017 | 343 | 137 | ||
| Adjuvant system AS01: helping to overcome the challenges of modern vaccines | Expert Review of Vaccines | | 2017 | 315 | 1 | ||
| Predicting RTS,S vaccine-mediated protection from transcriptomes in a malaria-challenge clinical trial | Frontiers in Immunology | | 2017 | 303 | 377 | ||
| Lysosome-dependent activation of human dendritic cells by the vaccine adjuvant QS-21 | Frontiers in Immunology | | 2017 | 282 | 280 | ||
| Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans | Frontiers in Immunology | | 2017 | 297 | 157 | ||
| The lymphatic immune response induced by the adjuvant AS01 : a comparison of intramuscular and subcutaneous immunization routes | The Journal of immunology | | 2016 | 92 | 498 |
